Biolase (NASDAQ:BIOL) Receiving Somewhat Positive Press Coverage, Accern Reports
Biolase logo News stories about Biolase (NASDAQ:BIOL) have trended somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public …